Trial Outcomes & Findings for Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System (NCT NCT04041700)

NCT ID: NCT04041700

Last Updated: 2021-08-18

Results Overview

Free field (Pure Tone Average 4, mean of 0.5, 1,2 and 4 kHz)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

29 participants

Primary outcome timeframe

Baseline before surgery, 3 months after surgery

Results posted on

2021-08-18

Participant Flow

29 participants were recruited in three centres from 16 August 2019 to 24 September 2020.

Participant milestones

Participant milestones
Measure
Osia 2 System
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Overall Study
STARTED
29
Overall Study
COMPLETED
27
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Osia 2 System
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Overall Study
Pregnancy
1
Overall Study
Unable to visit the site due to the Covid-19 travel restrictions
1

Baseline Characteristics

Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Age, Continuous
46.7 years
STANDARD_DEVIATION 19.7 • n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
3 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
23 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=5 Participants
Region of Enrollment
Hong Kong
3 participants
n=5 Participants
Region of Enrollment
Australia
26 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline before surgery, 3 months after surgery

Population: Data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit.

Free field (Pure Tone Average 4, mean of 0.5, 1,2 and 4 kHz)

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 3 Months Post-surgery Compared to Preoperative Unaided Condition Assessed Via Audiometric Thresholds
-27.3 db HL (decibel Hearing Level)
Standard Deviation 8.7

PRIMARY outcome

Timeframe: Baseline before surgery, 3 months after surgery

Population: Data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit.

Speech-to-noise ratio, 50% speech understanding

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 3 Months Post-surgery Compared to Preoperative Unaided Situation Assessed Via Adaptive Speech Recognition in Noise
-9.10 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 7.88

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks and 6 months after surgery

Population: At 4 weeks, data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit. At 6 months visit, data was received for 28 participants.The participant that did not attend previous visits did visit the site and data was collected. The participant that did not receive the sound processor still could not visit site.

Free field (Pure Tone Average 4, mean of 0.5, 1,2 and 4 kHz)

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 4 Weeks and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
4 weeks
-25.6 db HL (decibel Hearing Level)
Standard Deviation 8.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
6 months
-28.4 db HL (decibel Hearing Level)
Standard Deviation 9.6

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks and 6 months after surgery

Population: At 4 weeks, data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit. At 6 months visit, data was received for 28 participants.The participant that did not attend previous visits did visit the site and data was collected. The participant that did not receive the sound processor still could not visit site.

Speech-to-noise ratio, 50% speech understanding

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 4 Weeks and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Adaptive Speech Recognition in Noise
4 weeks
-8.76 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 8.06
Change in Hearing Performance With the Osia 2 System at 4 Weeks and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Adaptive Speech Recognition in Noise
6 months
-8.84 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 7.88

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: At the 4 weeks and 3 months visits, data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit. At the 6 months visit, data was received for 28 participants. The participant that did not attend previous visits did visit the site and data was collected. The participant that did not receive the sound processor still could not visit site.

Free-field \[0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz\]

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.25 kHz, 4 weeks
-13.5 db HL (decibel Hearing Level)
Standard Deviation 12.0
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.5 kHz, 4 weeks
-23.1 db HL (decibel Hearing Level)
Standard Deviation 12.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.75 kHz, 4 weeks
-30.2 db HL (decibel Hearing Level)
Standard Deviation 10.6
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.0 kHz, 4 weeks
-28.3 db HL (decibel Hearing Level)
Standard Deviation 10.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.5 kHz, 4 weeks
-30.0 db HL (decibel Hearing Level)
Standard Deviation 10.7
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
2.0 kHz, 4 weeks
-25.7 db HL (decibel Hearing Level)
Standard Deviation 9.7
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
3.0 kHz, 4 weeks
-24.8 db HL (decibel Hearing Level)
Standard Deviation 11.6
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
4.0 kHz, 4 weeks
-25.4 db HL (decibel Hearing Level)
Standard Deviation 11.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
6.0 kHz, 4 weeks
-35.0 db HL (decibel Hearing Level)
Standard Deviation 11.9
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
8.0 kHz, 4 weeks
-5.44 db HL (decibel Hearing Level)
Standard Deviation 12.9
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.25 kHz, 3 months
-14.8 db HL (decibel Hearing Level)
Standard Deviation 11.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.5 kHz, 3 months
-24.4 db HL (decibel Hearing Level)
Standard Deviation 11.2
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.75 kHz, 3 months
-32.0 db HL (decibel Hearing Level)
Standard Deviation 10.8
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.0 kHz, 3 months
-29.1 db HL (decibel Hearing Level)
Standard Deviation 10.2
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.5 kHz, 3 months
-30.6 db HL (decibel Hearing Level)
Standard Deviation 11.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
2.0 kHz, 3 months
-27.0 db HL (decibel Hearing Level)
Standard Deviation 10.9
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
3.0 kHz, 3 months
-25.2 db HL (decibel Hearing Level)
Standard Deviation 11.5
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
4.0 kHz, 3 months
-28.7 db HL (decibel Hearing Level)
Standard Deviation 11.5
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
6.0 kHz, 3 months
-36.5 db HL (decibel Hearing Level)
Standard Deviation 12.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
8.0 kHz, 3 months
-8.59 db HL (decibel Hearing Level)
Standard Deviation 13.8
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.25 kHz, 6 months
-14.3 db HL (decibel Hearing Level)
Standard Deviation 12.8
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.5 kHz, 6 months
-24.6 db HL (decibel Hearing Level)
Standard Deviation 12.2
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
0.75 kHz, 6 months
-32.0 db HL (decibel Hearing Level)
Standard Deviation 11.5
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.0 kHz, 6 months
-31.3 db HL (decibel Hearing Level)
Standard Deviation 11.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
1.5 kHz, 6 months
-33.8 db HL (decibel Hearing Level)
Standard Deviation 10.9
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
2.0 kHz, 6 months
-28.4 db HL (decibel Hearing Level)
Standard Deviation 12.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
3.0 kHz, 6 months
-26.6 db HL (decibel Hearing Level)
Standard Deviation 9.9
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
4.0 kHz, 6 months
-29.3 db HL (decibel Hearing Level)
Standard Deviation 11.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
6.0 kHz, 6 months
-37.3 db HL (decibel Hearing Level)
Standard Deviation 12.5
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Audiometric Thresholds
8.0 kHz, 6 months
-7.71 db HL (decibel Hearing Level)
Standard Deviation 15.9

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: At the 4 weeks and 3 months visits, data was only received for 27 participants. One participant did not receive the sound processor due to the Covid-19 pandemic and one participant did not attend neither the 4 weeks visit nor the 3 months visit. At the 6 months visit, data was received for 28 participants. The participant that did not attend previous visits did visit the site and data was collected. The participant that did not receive the sound processor still could not visit site.

% correctly perceived words at 50dB, 65dB and 80dB SPL

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 4 weeks
62.7 Percentage of correct words
Standard Deviation 20.7
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 4 weeks
55.1 Percentage of correct words
Standard Deviation 29.4
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 4 weeks
23.9 Percentage of correct words
Standard Deviation 27.5
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 3 months
63.8 Percentage of correct words
Standard Deviation 21.6
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 3 months
55.5 Percentage of correct words
Standard Deviation 29.3
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 3 months
23.7 Percentage of correct words
Standard Deviation 27.7
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 6 months
62.3 Percentage of correct words
Standard Deviation 22.1
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 6 months
54.0 Percentage of correct words
Standard Deviation 29.8
Change in Hearing Performance With the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Compared to Preoperative Unaided Situation Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 6 months
24.3 Percentage of correct words
Standard Deviation 28.0

SECONDARY outcome

Timeframe: Baseline before surgery, 3 months and 6 months after surgery

Population: One participant did not receive the sound processor and did not perform this questionnaire at either 3- or 6-months visit. One participant did not perform this questionnaire at 3-month visit and another participant did not perform this questionnaire at the 6-month visit.

Measuring change of Ease of communication, Reverberation, Background noise, Aversiveness and a Global score with the Osia 2 System from the pre-operative unaided situation. The absolute APHAB scale is between 0 and 100%, where 0% indicates no problems and 100% indicates always problem. The change from unaided to aided hearing is presented. A positive value indicates an impairment, a negative value an improvement.

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Ease of communication, 3 months
28.1 units on a scale
Standard Deviation 30.7
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Background Noise, 3 months
27.6 units on a scale
Standard Deviation 26.9
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Reverberation, 3 months
20.3 units on a scale
Standard Deviation 24.3
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Aversiveness, 3 months
-5.2 units on a scale
Standard Deviation 34.9
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Global, 3 months
25.4 units on a scale
Standard Deviation 25.0
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Ease of communication, 6 months
27.4 units on a scale
Standard Deviation 31.4
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Background Noise, 6 months
28.7 units on a scale
Standard Deviation 28.1
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Reverberation, 6 months
21.7 units on a scale
Standard Deviation 26.4
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Aversiveness, 6 months
-0.212 units on a scale
Standard Deviation 33.0
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
APHAB - Global, 6 months
25.9 units on a scale
Standard Deviation 26.2

SECONDARY outcome

Timeframe: Baseline before surgery, 3 months and 6 months after surgery

Population: One participant did not receive the sound processor and did not perform this questionnaire at either 3- or 6-months visit. One participant did not perform this questionnaire at 3-month visit and another participant did not perform this questionnaire at the 6-month visit.

Measuring change of speech, spatial and hearing experiences with the Osia 2 System from the pe-operative unaided situation. A scale from 0 to 10 is used, where 0 represents "can not hear at all", and 10 "hear perfectly". The change from unaided to aided hearing is presented. A positive value indicates improved hearing, a negative value indicates impaired hearing.

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Total score, 3 months
2.88 Score on a scale
Standard Deviation 1.56
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Speech score, 3 months
3.12 Score on a scale
Standard Deviation 1.78
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Spatial score, 3 months
2.92 Score on a scale
Standard Deviation 2.07
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Quality score, 3 months
2.55 Score on a scale
Standard Deviation 1.78
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Total score, 6 months
2.50 Score on a scale
Standard Deviation 1.66
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Speech score, 6 months
2.68 Score on a scale
Standard Deviation 1.89
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Spatial score, 6 months
2.30 Score on a scale
Standard Deviation 2.42
Change in Self-reported Hearing Outcome With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Speech, Spatial and Qualities of Hearing Scale (SSQ) Questionnaire
SSQ12 Quality score, 6 months
2.41 Score on a scale
Standard Deviation 1.81

SECONDARY outcome

Timeframe: Baseline before surgery, 3 months and 6 months after surgery

Population: One participant did not receive the sound processor and did not perform this questionnaire at either 3- or 6-months visit. One participant did not perform this questionnaire at 3-month visit and another participant did not perform this questionnaire at the 6-month visit.

Change of health status and health related quality of life using the generic quality of life scale Health Utilities Index (HUI3) when wearing Osia 2 System compared to the pre-operative unaided situation. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change from unaided to aided hearing is presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Comprehensive Health State, 3 months
0.097 score on a scale
Standard Deviation 0.167
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Vision attribute, 3 months
0.002 score on a scale
Standard Deviation 0.017
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Hearing attribute, 3 months
0.113 score on a scale
Standard Deviation 0.288
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Speech attribute, 3 months
0.006 score on a scale
Standard Deviation 0.076
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Ambulation attribute, 3 months
-0.006 score on a scale
Standard Deviation 0.033
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Dexterity attribute, 3 months
0.031 score on a scale
Standard Deviation 0.117
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Emotion attribute, 3 months
0.033 score on a scale
Standard Deviation 0.071
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Cognition attribute, 3 months
0.011 score on a scale
Standard Deviation 0.040
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Pain attribute (HUI3), 3 months
0.009 score on a scale
Standard Deviation 0.061
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Comprehensive Health State, 6 months
0.091 score on a scale
Standard Deviation 0.165
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Vision attribute, 6 months
-0.004 score on a scale
Standard Deviation 0.013
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Hearing attribute, 6 months
0.129 score on a scale
Standard Deviation 0.318
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Speech attribute, 6 months
0.000 score on a scale
Standard Deviation 0.106
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Ambulation attribute, 6 months
0.013 score on a scale
Standard Deviation 0.045
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Dexterity attribute, 6 months
0.026 score on a scale
Standard Deviation 0.120
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Emotion attribute, 6 months
0.020 score on a scale
Standard Deviation 0.063
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Cognition attribute, 6 months
0.001 score on a scale
Standard Deviation 0.064
Change in Health-related Quality of Life With the Osia 2 System at 3 Months and 6 Months Post Surgery Compared to the Preoperative Unaided Situation Via the Health Utilities Index Mark III (HUI) Questionnaire
Pain attribute (HUI3), 6 months
0.011 score on a scale
Standard Deviation 0.123

SECONDARY outcome

Timeframe: Baseline before surgery or at surgery

Measured in mm

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Soft Tissue Thickness
6.62 mm
Standard Deviation 1.29

SECONDARY outcome

Timeframe: At surgery

Population: Surgery time was not measured for one of the participants.

Time in minutes between first incision to last suture

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Surgery Time
52.8 min
Standard Deviation 13.3

SECONDARY outcome

Timeframe: At surgery

Yes/No

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Bone Polishing/Removal at the Actuator Site
Yes
12 Participants
Surgical Information: Bone Polishing/Removal at the Actuator Site
No
17 Participants

SECONDARY outcome

Timeframe: At surgery

3 mm/4 mm

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: BI300 Implant Length
3 mm
0 Participants
Surgical Information: BI300 Implant Length
4 mm
29 Participants

SECONDARY outcome

Timeframe: At surgery

Population: Data only gathered for 26 participants.

Measured in mm between the ear canal and the center of the actuator

Outcome measures

Outcome measures
Measure
Osia 2 System
n=26 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Location of BI300 Implant
52.9 mm
Standard Deviation 7.3

SECONDARY outcome

Timeframe: At surgery

General/local

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Type of Anesthesia
General
29 Participants
Surgical Information: Type of Anesthesia
Local
0 Participants

SECONDARY outcome

Timeframe: At surgery

Yes/No

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Soft Tissue Reduction
Yes
0 Participants
Surgical Information: Soft Tissue Reduction
No
29 Participants

SECONDARY outcome

Timeframe: At surgery

Examples: C-shaped/S-shaped/straight

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Surgical Incision Type
C-shaped
12 Participants
Surgical Information: Surgical Incision Type
S-shaped
12 Participants
Surgical Information: Surgical Incision Type
Other
5 Participants
Surgical Information: Surgical Incision Type
Straight
0 Participants

SECONDARY outcome

Timeframe: At surgery

Anterior/posterior

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Location of the Surgical Incision in Relation to the Actuator
Posterior
3 Participants
Surgical Information: Location of the Surgical Incision in Relation to the Actuator
Anterior
26 Participants

SECONDARY outcome

Timeframe: At surgery

Measured in mm

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Estimated Length of the Surgical Incision
71.4 mm
Standard Deviation 23.1

SECONDARY outcome

Timeframe: At surgery

Periosteal pocket (under periosteal)/on top of periosteum/on top of muscle)

Outcome measures

Outcome measures
Measure
Osia 2 System
n=29 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Surgical Information: Placement of the Coil
Periosteal pocket (under periosteal)
24 Participants
Surgical Information: Placement of the Coil
on top of periosteum
3 Participants
Surgical Information: Placement of the Coil
on top of muscle
2 Participants

SECONDARY outcome

Timeframe: At 4 weeks, 6 weeks, 3 months and 6 months after surgery

Population: For some participants the data are not available at all visits.

Magnet strength ranging from 1 to 4 where 1 is the weakest and 4 the strongest. A magnet allows the external sound processor to be placed in the correct position over the implanted system including an internal magnet.

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Magnet Choice
Magnet strength 2, 4 weeks
1 Participants
Usability Information: Magnet Choice
Magnet strength 3, 4 weeks
11 Participants
Usability Information: Magnet Choice
Magnet strength 4, 4 weeks
16 Participants
Usability Information: Magnet Choice
Magnet strength 2, 6 weeks
1 Participants
Usability Information: Magnet Choice
Magnet strength 3, 6 weeks
13 Participants
Usability Information: Magnet Choice
Magnet strength 4, 6 weeks
13 Participants
Usability Information: Magnet Choice
Magnet strength 2, 3 months
4 Participants
Usability Information: Magnet Choice
Magnet strength 3, 3 months
10 Participants
Usability Information: Magnet Choice
Magnet strength 4, 3 months
14 Participants
Usability Information: Magnet Choice
Magnet strength 2, 6 months
4 Participants
Usability Information: Magnet Choice
Magnet strength 3, 6 months
12 Participants
Usability Information: Magnet Choice
Magnet strength 4, 6 months
11 Participants

SECONDARY outcome

Timeframe: At 4 weeks, 6 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

Assessed via a Visual Analog Scale 100 mm where 0 mm represents insufficient retention and 100 mm excellent retention

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Sound Processor Retention
Overall Retention, 4 weeks
72.1 units on a scale
Standard Deviation 22.8
Usability Information: Sound Processor Retention
Overall Retention, 6 weeks
86.9 units on a scale
Standard Deviation 13.9
Usability Information: Sound Processor Retention
Overall Retention, 3 months
80.4 units on a scale
Standard Deviation 17.1
Usability Information: Sound Processor Retention
Overall Retention, 6 months
71.4 units on a scale
Standard Deviation 26.7

SECONDARY outcome

Timeframe: At 4 weeks, 6 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

Assessed via a Visual Analog Scale 100 mm where 0 mm represents no comfort at all and 100 mm excellent comfort

Outcome measures

Outcome measures
Measure
Osia 2 System
n=27 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Sound Processor Wearing Comfort
Overall Comfort, 4 weeks
81.7 units on a scale
Standard Deviation 14.1
Usability Information: Sound Processor Wearing Comfort
Overall Comfort, 6 weeks
87.1 units on a scale
Standard Deviation 16.8
Usability Information: Sound Processor Wearing Comfort
Overall Comfort, 3 months
83.5 units on a scale
Standard Deviation 16.4
Usability Information: Sound Processor Wearing Comfort
Overall Comfort, 6 months
81.4 units on a scale
Standard Deviation 20.0

SECONDARY outcome

Timeframe: At 6 weeks, 3 months and 6 months after surgery

Population: For some participants the data are not available at all visits.

Yes/No

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Use of SoftWear Pad
Yes, 6 weeks
3 Participants
Usability Information: Use of SoftWear Pad
No, 6 weeks
24 Participants
Usability Information: Use of SoftWear Pad
Yes, 3 months
4 Participants
Usability Information: Use of SoftWear Pad
No, 3 months
24 Participants
Usability Information: Use of SoftWear Pad
Yes, 6 months
2 Participants
Usability Information: Use of SoftWear Pad
No, 6 months
25 Participants

SECONDARY outcome

Timeframe: At 6 weeks, 3 months and 6 months after surgery

Population: For some participants the data are not available at all visits.

Average hours of daily use

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Daily Use of Sound Processor
Daily use, 6 weeks
10.3 hours/day
Standard Deviation 4.4
Usability Information: Daily Use of Sound Processor
Daily use, 3 months
9.57 hours/day
Standard Deviation 4.19
Usability Information: Daily Use of Sound Processor
Daily use, 6 months
8.63 hours/day
Standard Deviation 4.67

SECONDARY outcome

Timeframe: At 6 weeks, 3 months and 6 months after surgery

Population: For some participants the data are not available at all visits.

Average hours of daily streaming

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Daily Streaming Time of Sound Processor
Streaming, 6 weeks
0.407 hours/day
Standard Deviation 0.931
Usability Information: Daily Streaming Time of Sound Processor
Streaming, 3 months
0.536 hours/day
Standard Deviation 0.962
Usability Information: Daily Streaming Time of Sound Processor
Streaming, 6 months
0.444 hours/day
Standard Deviation 0.698

SECONDARY outcome

Timeframe: At 6 weeks, 3 months and 6 months after surgery

Population: For some participants the data are not available at all visits.

Average hours of battery lifetime

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Usability Information: Battery Lifetime of Sound Processor
6 weeks
27.3 hours
Standard Deviation 15.0
Usability Information: Battery Lifetime of Sound Processor
3 months
27.4 hours
Standard Deviation 11.2
Usability Information: Battery Lifetime of Sound Processor
6 months
24.3 hours
Standard Deviation 12.4

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

Free-field \[Pure Tone Average (PTA) 4, Mean of 0.5, 1, 2 and 4 kHz\].

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
PTA4, 4 weeks
0.046 db HL (decibel Hearing Level)
Standard Deviation 7.134
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
PTA4, 3 months
-1.62 db HL (decibel Hearing Level)
Standard Deviation 6.41
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
PTA4, 6 months
-2.54 db HL (decibel Hearing Level)
Standard Deviation 8.32

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

Free-field \[0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz\].

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.25 kHz, 4 weeks
4.44 db HL (decibel Hearing Level)
Standard Deviation 13.18
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.5 kHz, 4 weeks
4.44 db HL (decibel Hearing Level)
Standard Deviation 10.13
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.75 kHz, 4 weeks
-0.741 db HL (decibel Hearing Level)
Standard Deviation 6.893
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.0 kHz, 4 weeks
1.85 db HL (decibel Hearing Level)
Standard Deviation 7.61
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.5 kHz, 4 weeks
0.185 db HL (decibel Hearing Level)
Standard Deviation 8.376
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
2.0 kHz, 4 weeks
-2.22 db HL (decibel Hearing Level)
Standard Deviation 8.70
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
3.0 kHz, 4 weeks
-1.48 db HL (decibel Hearing Level)
Standard Deviation 10.27
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
4.0 kHz, 4 weeks
-3.89 db HL (decibel Hearing Level)
Standard Deviation 11.21
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
6.0 kHz, 4 weeks
-11.9 db HL (decibel Hearing Level)
Standard Deviation 10.9
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
8.0 kHz, 4 weeks
4.78 db HL (decibel Hearing Level)
Standard Deviation 16.49
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.25 kHz, 3 months
3.15 db HL (decibel Hearing Level)
Standard Deviation 10.57
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.5 kHz, 3 months
3.15 db HL (decibel Hearing Level)
Standard Deviation 9.11
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.75 kHz, 3 months
-2.59 db HL (decibel Hearing Level)
Standard Deviation 6.70
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.0 kHz, 3 months
1.11 db HL (decibel Hearing Level)
Standard Deviation 6.55
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.5 kHz, 3 months
-0,370 db HL (decibel Hearing Level)
Standard Deviation 7,836
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
2.0 kHz, 3 months
-3.52 db HL (decibel Hearing Level)
Standard Deviation 8.64
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
3.0 kHz, 3 months
-1.85 db HL (decibel Hearing Level)
Standard Deviation 10.48
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
4.0 kHz, 3 months
-7.22 db HL (decibel Hearing Level)
Standard Deviation 10.41
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
6.0 kHz, 3 months
-13.3 db HL (decibel Hearing Level)
Standard Deviation 10.3
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
8.0 kHz, 3 months
1.63 db HL (decibel Hearing Level)
Standard Deviation 15.20
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.25 kHz, 6 months
3.93 db HL (decibel Hearing Level)
Standard Deviation 13.77
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.5 kHz, 6 months
2.86 db HL (decibel Hearing Level)
Standard Deviation 9.95
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
0.75 kHz, 6 months
-2.68 db HL (decibel Hearing Level)
Standard Deviation 8.76
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.0 kHz, 6 months
-1.07 db HL (decibel Hearing Level)
Standard Deviation 7.98
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
1.5 kHz, 6 months
-3.39 db HL (decibel Hearing Level)
Standard Deviation 7.34
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
2.0 kHz, 6 months
-4.64 db HL (decibel Hearing Level)
Standard Deviation 10.97
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
3.0 kHz, 6 months
-3.04 db HL (decibel Hearing Level)
Standard Deviation 12.35
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
4.0 kHz, 6 months
-7.32 db HL (decibel Hearing Level)
Standard Deviation 11.26
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
6.0 kHz, 6 months
-13.9 db HL (decibel Hearing Level)
Standard Deviation 13.6
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Audiometric Thresholds
8.0 kHz, 6 months
2.86 db HL (decibel Hearing Level)
Standard Deviation 17.87

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

Signal-to-noise ratio, 50% speech understanding

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Adaptive Speech Recognition in Noise
4 weeks
-0.870 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 1.366
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Adaptive Speech Recognition in Noise
3 months
-1.21 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 1.42
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Adaptive Speech Recognition in Noise
6 months
-0.846 db SNR (decibel Speech in Noise Ratio)
Standard Deviation 1.587

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform all tests at all visits.

% correctly perceived words at 50dB, 65dB and 80dB SPL

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 4 weeks
12.2 Percentage of correct words
Standard Deviation 18.3
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 4 weeks
9.77 Percentage of correct words
Standard Deviation 14.76
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 4 weeks
2.88 Percentage of correct words
Standard Deviation 10.21
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 3 months
13.2 Percentage of correct words
Standard Deviation 18.8
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 3 months
10.1 Percentage of correct words
Standard Deviation 16.0
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 3 months
2.66 Percentage of correct words
Standard Deviation 10.13
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 50 dB, 6 months
10.7 Percentage of correct words
Standard Deviation 18.3
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 65 dB, 6 months
8.84 Percentage of correct words
Standard Deviation 15.22
Difference in Hearing Performance Between the Osia 2 System and a Baha 5 Power Sound Processor on a Baha Softband (Preoperative) at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Speech Recognition in Quiet
Speech in quiet at 80 dB, 6 months
4.00 Percentage of correct words
Standard Deviation 8.26

SECONDARY outcome

Timeframe: Baseline before surgery, 4 weeks, 3 months and 6 months after surgery

Population: Some participants did not perform the test at all visits.

BC direct (0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0 and 6.0 kHz)

Outcome measures

Outcome measures
Measure
Osia 2 System
n=28 Participants
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 250 Hz, baseline
13.2 db HL (decibel Hearing Level)
Standard Deviation 10.2
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 500 Hz, baseline
24.7 db HL (decibel Hearing Level)
Standard Deviation 11.3
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 750 Hz, baseline
20.7 db HL (decibel Hearing Level)
Standard Deviation 12.4
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1000 Hz, baseline
20.0 db HL (decibel Hearing Level)
Standard Deviation 13.5
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1500 Hz, baseline
19.1 db HL (decibel Hearing Level)
Standard Deviation 14.6
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 2000 Hz, baseline
31.2 db HL (decibel Hearing Level)
Standard Deviation 15.3
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 3000 Hz, baseline
36.8 db HL (decibel Hearing Level)
Standard Deviation 18.7
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 4000 Hz, baseline
43.5 db HL (decibel Hearing Level)
Standard Deviation 17.6
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 6000 Hz, baseline
46.1 db HL (decibel Hearing Level)
Standard Deviation 17.6
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 250 Hz, 4 weeks
5.18 db HL (decibel Hearing Level)
Standard Deviation 12.87
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 500 Hz, 4 weeks
14.5 db HL (decibel Hearing Level)
Standard Deviation 8.7
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 750 Hz, 4 weeks
5.71 db HL (decibel Hearing Level)
Standard Deviation 11.20
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1000 Hz, 4 weeks
9.46 db HL (decibel Hearing Level)
Standard Deviation 11.33
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1500 Hz, 4 weeks
7.50 db HL (decibel Hearing Level)
Standard Deviation 13.23
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 2000 Hz, 4 weeks
12.0 db HL (decibel Hearing Level)
Standard Deviation 14.2
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 3000 Hz, 4 weeks
13.9 db HL (decibel Hearing Level)
Standard Deviation 15.4
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 4000 Hz, 4 weeks
23.8 db HL (decibel Hearing Level)
Standard Deviation 17.1
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 6000 Hz, 4 weeks
22.0 db HL (decibel Hearing Level)
Standard Deviation 18.7
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 250 Hz, 3 months
4.00 db HL (decibel Hearing Level)
Standard Deviation 11.21
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 500 Hz, 3 months
13.0 db HL (decibel Hearing Level)
Standard Deviation 9.8
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 750 Hz, 3 months
4.33 db HL (decibel Hearing Level)
Standard Deviation 12.08
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1000 Hz, 3 months
9.67 db HL (decibel Hearing Level)
Standard Deviation 13.29
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1500 Hz, 3 months
6.67 db HL (decibel Hearing Level)
Standard Deviation 15.43
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 2000 Hz, 3 months
14.0 db HL (decibel Hearing Level)
Standard Deviation 15.9
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 3000 Hz, 3 months
13.3 db HL (decibel Hearing Level)
Standard Deviation 18.5
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 4000 Hz, 3 months
24.3 db HL (decibel Hearing Level)
Standard Deviation 17.4
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 6000 Hz, 3 months
27.0 db HL (decibel Hearing Level)
Standard Deviation 18.5
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 250 Hz, 6 months
8.10 db HL (decibel Hearing Level)
Standard Deviation 13.83
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 500 Hz, 6 months
15.0 db HL (decibel Hearing Level)
Standard Deviation 8.5
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 750 Hz, 6 months
6.90 db HL (decibel Hearing Level)
Standard Deviation 12.60
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1000 Hz, 6 months
10.7 db HL (decibel Hearing Level)
Standard Deviation 11.3
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 1500 Hz, 6 months
5.95 db HL (decibel Hearing Level)
Standard Deviation 13.84
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 2000 Hz, 6 months
14.3 db HL (decibel Hearing Level)
Standard Deviation 13.7
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 3000 Hz, 6 months
13.6 db HL (decibel Hearing Level)
Standard Deviation 17.0
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 4000 Hz, 6 months
25.7 db HL (decibel Hearing Level)
Standard Deviation 16.9
Hearing Performance Using a Baha Softband (Preoperative) at Baseline and the Osia 2 System at 4 Weeks, 3 Months and 6 Months Post Surgery Assessed Via Bone Conduction (BC) Direct
BC Direct 6000 Hz, 6 months
25.0 db HL (decibel Hearing Level)
Standard Deviation 18.8

Adverse Events

Osia 2 System

Serious events: 3 serious events
Other events: 21 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Osia 2 System
n=29 participants at risk
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Infections and infestations
Gastroenteritis
3.4%
1/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Infections and infestations
Infected Skin/ Wound With Subcutaneous Collection
3.4%
1/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Infections and infestations
Infected Wound/Possible Flap Compromise
3.4%
1/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Cardiac disorders
Preoperative Bradycardia
3.4%
1/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.

Other adverse events

Other adverse events
Measure
Osia 2 System
n=29 participants at risk
Osia 2 system: System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.
Ear and labyrinth disorders
Ear and labyrinth disorders - Other
17.2%
5/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
General disorders
General disorders and administration site conditions - Other
17.2%
5/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Infections and infestations
Wound infection
13.8%
4/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Injury, poisoning and procedural complications
Wound complication
20.7%
6/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Musculoskeletal and connective tissue disorders
Neck pain
6.9%
2/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.
Psychiatric disorders
Psychiatric Disorders - Other
6.9%
2/29 • Number of events 29 • 6 months
Adverse events are presented by the CTCAE term.

Additional Information

Johan Blechert

Cochlear

Phone: +46766498632

Results disclosure agreements

  • Principal investigator is a sponsor employee The institutions agree that no publication of the study results may be made until publication of the results of the multi-centre study or 2 years after study completion, whichever is the sooner.
  • Publication restrictions are in place

Restriction type: OTHER